Cryopyrin Associated Periodic Syndromes (caps) - Histology

Relevant Publications

Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry.

Issue Release: 2024

HSP90β controls NLRP3 autoactivation.

Issue Release: 2024

Refining Treat-to-Target (T2T) strategies in Cryopyrin-Associated Periodic Syndromes (CAPS): The role of inflammatory markers.

Issue Release: 2024

Implication of the LRR Domain in the Regulation and Activation of the NLRP3 Inflammasome.

Issue Release: 2024

Case Report: Efficacy, safety, and favorable long-term outcome of early treatment with IL-1 inhibitors in a patient with chronic infantile neurological cutaneous articular (CINCA) syndrome caused by NLRP3 mosaicism.

Issue Release: 2024

Long-term renal outcome of Cryopyrin-associated periodic syndrome (CAPS) under anti-Interleukin-1 therapy.

Issue Release: 2024

Update on ocular manifestations of the main monogenic and polygenic autoinflammatory diseases.

Issue Release: 2024

Practical Approach to Diagnosis and Management of IL-1-Mediated Autoinflammatory Diseases (CAPS, TRAPS, MKD, and DIRA).

Issue Release: 2024

[Hereditary systemic autoinflammatory diseases associated with cryopyrin].

Issue Release: 2023

A Knock-In Mouse Model of Cryopyrin-Associated Periodic Syndromes.

Issue Release: 2023

Socio-professional impact and quality of life of cryopyrin-associated periodic syndromes in 54 patients in adulthood.

Issue Release: 2023

Chronic recurrent wheals - If not chronic spontaneous urticaria, what else?

Issue Release: 2023

Papilledema as a possible key sign for diagnosis of cryopyrin-associated periodic syndromes (CAPS): A case report.

Issue Release: 2023

Parthenolide targets NLRP3 to treat inflammasome-related diseases.

Issue Release: 2023

Case Report: A variant resulting in autoinflammatory disease in a Chinese newborn.

Issue Release: 2023

Antisense Oligonucleotide Therapy Decreases IL-1β Expression and Prolongs Survival in Mutant Nlrp3 Mice.

Issue Release: 2023

The assessment of autoinflammatory disease classification criteria (Eurofever/PRINTO) in a real-life cohort.

Issue Release: 2023

Similarities and differences in autoinflammatory diseases with urticarial rash, cryopyrin-associated periodic syndrome and Schnitzler syndrome.

Issue Release: 2023

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZY-IL1 in Three Patients with Cryopyrin-Associated Periodic Syndromes.

Issue Release: 2023

Evaluation of common NLRP3 Q703K variant in pediatric patients with autoinflammatory disease: CAPS and PFAPA.

Issue Release: 2023

How Does EBUS Relate to Histology?

What are Calcium Binding Motifs?

What Future Directions Are Expected in This Field?

How do you prepare a tissue sample for histological examination?

What are the Challenges in Cancer Imaging?

How are IGFs Regulated?

How Does Myeloperoxidase Affect Histological Observations?

What is the Future of Research in Axonal Damage?

What is the Role of Laminin in Development?

How to Optimize Rhodamine B Staining?

Partnered Content Networks

Relevant Topics